Curbing Minnesota’s opioid crisis means owners of sick pets may need to make more trips to their pharmacies.
At the beginning of August Minnesota put a new opioid law into effect. Certain aspects of the law have caused confusion and concern in the veterinary community. The new law puts a time limit on when opioid prescriptions can be filled. Cody Wiberg, the executive director of the Board of Pharmacy explains that the 30-day rule is meant to bring patients back in to be re-evaluated. The parameters of the law are supposed to help curb the opioid problem in Minnesota; and it has implications for the pet / vet community. One goal is to prevent people from accessing opioid medications for themselves through their vet’s office.
Ultimately, the concern is pet owners will need to return to their veterinarians for a pet check-up every 30 days, which can get expensive. And because a pet may only need a pain medication infrequently, there’s the risk of having more of the drug on-hand than is necessary.
Due to some questionable language used in the law, the Board plans to make some change recommendations at their next session. Luckily for some pet owners, a prescription on a lower class of drug such as Tramadol can be phoned to a pharmacy by a veterinarian, so an appointment is not necessary. Some stronger drug classes will need an appointment before a refill is granted.
All information obtained from, https://minnesota.cbslocal.com/2019/07/23/pet-owners-find-new-challenges-filling-prescriptions-over-new-opioid-laws/
Posted by: BP, Smart Hemp CBD
Look for “Follow Our Blog via Email” in the right hand column and add your email address to receive notices of newly published blog content. Thank you for reading!
Smart Hemp CBD Blog is sponsored by MySmartHempCBD.com – an online store with a full range of CBD products for pets – dogs, cats and horses. Be sure to visit!
The views in this blog are not to be interpreted as medical advice for pets. Consult your physician or veterinarian when making personal or pet medical decisions. CBD is a supplement and has not been evaluated by the FDA — it is not meant to diagnose, treat, or cure any medical condition.